Industry
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Loading...
Open
49.70
Mkt cap
446M
Volume
92K
High
49.90
P/E Ratio
-5.73
52-wk high
98.00
Low
46.19
Div yield
N/A
52-wk low
30.00
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.